Crude and adjusted hazard ratios for end-stage renal disease for women with and without hypertension and diabetes during postpartum follow-up
| Group | End-stage renal disease | Incidence rate per 10 000 person-years | Crude HR (95% CI) | Adjusted* HR (95% CI) |
|---|---|---|---|---|
| Hypertension during follow-up | ||||
| No hypertensive disorders in pregnancy | 25 | 49.7 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 61 | 76.8 | 1.56 (0.98–2.48) | 1.51 (0.95–2.41) |
| No hypertension during follow-up | ||||
| No hypertensive disorders in pregnancy | 20 | 0.15 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 18 | 1.13 | 7.56 (4.00–14.3) | 6.67 (3.48–12.8) |
| Diabetes during follow-up | ||||
| No hypertensive disorders in pregnancy | 2 | 0.85 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 9 | 9.14 | 11.3 (2.44–52.4) | 10.6 (2.31–51.0) |
| No diabetes during follow-up | ||||
| No hypertensive disorders in pregnancy | 43 | 0.33 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 70 | 4.44 | 13.6 (9.33–19.9) | 11.9 (8.09–17.6) |
Note: CI = confidence interval, HR = hazard ratio.
↵* Adjusted for urbanization, coronary artery disease, congestive heart failure, hyperlipidemia and abruption.